Homegrown Firms Improve Business Focus

September 2006 | Company Finance Alert

With signs that the merger fever in Japan's pharmaceutical sector is cooling, newly merged local firms are improving their business focus. Daiichi-Sankyo, the indigenous sector's second-largest firm by sales, is to divest its reagents, chemicals and imaging businesses to two Japanese corporate

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.